Skip to main content


Log in

Analysis of Latent Tuberculosis Infection Treatment Adherence Among Refugees and Other Patient Groups Referred to the Baltimore City Health Department TB Clinic, February 2009–March 2011

  • Original Paper
  • Published:
Journal of Immigrant and Minority Health Aims and scope Submit manuscript


We sought to determine the proportion of refugee patients at the Baltimore City Health Department Tuberculosis program (BCHD-TB) successfully completing latent tuberculosis infection (LTBI) treatment, as compared to other referral groups, and to identify factors associated with treatment completion. We completed a retrospective cohort analysis of individuals referred to BCHD-TB program for LTBI care between February 1, 2009 and March 31, 2011. Among 841 patients evaluated by BCHD-TB and diagnosed with LTBI, 81 % of refugees, 50 % of non-refugee foreign-born, and 35 % of US-born patients completed LTBI treatment. In multivariate analysis, refugees had greater odds of LTBI treatment completion (Adjusted Odds Ratio 7.2; 95 % CI 4.2–12.4, p < 0.001) compared to US-born individuals adjusting for age, gender, and treatment regimen. Overall, LTBI treatment completion remains suboptimal. At BCHD-TB, LTBI treatment completion was significantly higher among refugees than other referral groups. Additional efforts are needed to optimize LTBI care, and future efforts may need to be tailored for different risk groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others


  1. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000;49:1–51.

    Google Scholar 

  2. Centers for Disease C, Prevention. Trends in tuberculosis—United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:201–5.

    Google Scholar 

  3. LoBue PA, Enarson DA, Thoen TC. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States. Int J Tuberc Lung Dis. 2010;14:1226–32.

    CAS  PubMed  Google Scholar 

  4. Geng E, Kreiswirth B, Driver C, Li J, Burzynski J, DellaLatta P, et al. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med. 2002;346:1453–8.

    Article  PubMed  Google Scholar 

  5. Horsburgh CR Jr, Rubin EJ. Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med. 2011;364:1441–8.

    Article  CAS  PubMed  Google Scholar 

  6. CDC. Latent Tuberculosis Infection: A Guide for Primary Health Care Providers. In; 2010.

  7. Cronin W. TB in Maryland: 2012 Epidemiologic Review. In: Talk presented at: Stop TB in my lifetime: meeting the challenge in Maryland meeting;. Clarksville, MD.

  8. Hirsch-Moverman Y, Daftary A, Franks J, Colson PW. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis. 2008;12:1235–54.

    CAS  PubMed  Google Scholar 

  9. Goswami ND, Gadkowski LB, Piedrahita C, Bissette D, Ahearn MA, Blain ML, et al. Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study. BMC Public Health. 2012;12:468.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Hirsch-Moverman Y, Bethel J, Colson PW, Franks J, El-Sadr W. Predictors of latent tuberculosis infection treatment completion in the United States: an inner city experience. Int J Tuberc Lung Dis. 2010;14:1104–11.

    CAS  PubMed  Google Scholar 

  11. Zuniga JA. Medication adherence in Hispanics to latent tuberculosis treatment: a literature review. J Immigr Minor Health. 2012;14:23–9.

    Article  PubMed  Google Scholar 

  12. Li J, Munsiff SS, Tarantino T, Dorsinville M. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Int J Infect Dis. 2010;14:e292–7.

    Article  PubMed  Google Scholar 

  13. Levesque JF, Dongier P, Brassard P, Allard R. Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada. Int J Tuberc Lung Dis. 2004;8:711–7.

    CAS  PubMed  Google Scholar 

  14. Trauer JM, Krause VL. Assessment and management of latent tuberculosis infection in a refugee population in the Northern Territory. Med J Aust. 2011;194:579–82.

    PubMed  Google Scholar 

  15. Centers for Disease C, Prevention. Trends in tuberculosis—United States. MMWR Morb Mortal Wkly Rep. 2011;2012(61):181–5.

    Google Scholar 

  16. Trajman A, Long R, Zylberberg D, Dion MJ, Al-Otaibi B, Menzies D. Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment. Int J Tuberc Lung Dis. 2010;14:551–9.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Maunank Shah.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nuzzo, J.B., Golub, J.E., Chaulk, P. et al. Analysis of Latent Tuberculosis Infection Treatment Adherence Among Refugees and Other Patient Groups Referred to the Baltimore City Health Department TB Clinic, February 2009–March 2011. J Immigrant Minority Health 17, 56–65 (2015).

Download citation

  • Published:

  • Issue Date:

  • DOI: